SecBot SecBot
SECBOTREPLAY Home › Report › IOVA

IOVA · Iovance Biotherapeutics lost a summary judgment ruling in its insurance…

IOVANCE BIOTHERAPEUTICS, INC. · COURT-RULING filed Jul 15, 2026 at 20:00 ET

At the news

BEARISHIMPACT 5/10

COURT-RULING filed Jul 15, 2026 at 20:00 ET

Iovance Biotherapeutics lost a summary judgment ruling in its insurance coverage dispute with Federal Insurance Company. The court held that Iovance's liability insurance policies expressly exclude coverage for contractually assumed obligations, barring recovery of reimbursement costs paid to clinical trial institutions for participant medical expenses. Iovance must now bear these costs, with no disclosed dollar amount, and faces an uphill appeal.

  • Iovance sought insurance coverage from Federal Insurance for reimbursement of medical expenses paid to five clinical trial institutions under Clinical Trial Agreements.
  • The court granted Federal's motion for summary judgment, ruling that the policies' contractual liability exclusion precludes coverage for Iovance's contractually owed reimbursements.
  • No third-party claims were filed by trial participants; the institutions sought payment under contract provisions, not tort liability.
  • Iovance's duty-to-defend claim also failed because no lawsuit or covered ADR proceeding was initiated.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access